StockComparison Logo
vs

FEMY vs CTXR

Comparison between Femasys Inc (FEMY, Company) and Citius Pharmaceuticals Inc (CTXR, Company).

Both FEMY and CTXR are from the Healthcare sector.

5-Year PerformanceFEMY has outperformed CTXR, delivering a return of -55.8% compared to -64.2%

FEMY vs CTXR - Performance Comparison

Key Characteristics

Financial metrics and valuation ratios

Market Cap
FEMY
$12M
Winner
CTXR
$12M
Max Drawdown
Winner
FEMY
98.40%
CTXR
99.66%
Sharpe Ratio
FEMY
-0.56
Winner
CTXR
0.12
5Y Beta
Winner
FEMY
1.09
CTXR
1.41
Industry
FEMY
Medical Instruments & Supplies
CTXR
Biotechnology
P/E Ratio
Winner
FEMY
-0.72
CTXR
-0.20
Forward P/E
FEMY
N/A
CTXR
0.32
5Y EPS CAGR
FEMY
N/A
CTXR
-20.51%
Debt to Equity
FEMY
0.00%
CTXR
0.00%

FEMY vs CTXR - Historical Returns

Returns include dividend reinvestment.

1M
FEMY
-44.32%
Winner
CTXR
+3.68%
3M
FEMY
-66.33%
Winner
CTXR
-33.82%
6M
FEMY
-74.67%
Winner
CTXR
-46.43%
1Y
FEMY
-77.05%
Winner
CTXR
-40.13%
5Y(CAGR)
Winner
FEMY
-55.82%
CTXR
-64.15%
10Y(CAGR)
FEMY
N/A
CTXR
-46.70%
Max(CAGR)
FEMY
-55.82%
Winner
CTXR
-46.70%

FEMY vs CTXR - Annual Returns (2017 - 2026)

Returns include dividend reinvestment.

YearFEMYCTXR
2026-68.27%-35.57%
2025-47.62%-79.97%
2024+8.91%-80.22%
2023+8.33%-3.01%
2022-77.44%-52.69%
2021-67.50%+48.08%
2020N/A+2.93%
2019N/A-5.56%
2018N/A-74.45%
2017N/A-37.70%

FEMY vs CTXR Drawdown Comparison

The maximum drawdown for FEMY was -98.40%, occurring on Jun 16, 2026. This drawdown has not yet recovered.

The maximum drawdown for CTXR was -99.66%, occurring on May 18, 2026. This drawdown has not yet recovered.

The current FEMY drawdown is -98.32%. The current CTXR drawdown is -99.65%.

RankFEMYCTXR
#1-98.40%
Jun 18, 2021 - Jun 16, 2026
-99.66%
Jul 12, 2017 - May 18, 2026
#2N/A-1.93%
Jul 10, 2017 - Jul 12, 2017

Correlation

Correlation between FEMY and CTXR is 0.77 which considered as a strong positive correlation - the stocks tend to move together.

0.77
-101

Select Stocks to Compare